Mishcon de Reya page structure
Site header
Main menu
Main content section

Inside Life Sciences

Issue 10: June 2020

Inside Life Sciences
 Post

Editor's Note

Welcome to the Spring 2020 edition of Inside Life Sciences.

News

COVID-19 and the Life Sciences Industry

The life sciences industry has, understandably, been at the forefront of discussions regarding the global COVID-19 pandemic, with evolving pressures and challenges on governments, the healthcare system and drug developers.

News
abstract-orange

High Court finds trade mark infringement through use of 'Merck'

In a long-running dispute between Merck KGaA (Merck Global) and US companies Merck Sharp & Dohme Corporation and Merck & Co (together Merck US), the High Court has decided that various uses of 'Merck' in the UK by Merck US, amount to trade mark infringement.

News
Mishcon de Reya interior

"Pay-for-Delay"

The Court of Justice of the European Union (the "CJEU") has given guidance on 'pay for delay' agreements for the first time in its recent decision in Generics (UK) v Competition and Markets Authority.

News

Patents Court considers 'clearing the way' and disclosure of launch plans

In Teva v Chiesi, the Patents Court has considered the extent to which a generic pharmaceutical company should clear the way to market before launch and the implications for an infringement counterclaim brought by a patentee based on a threat by the generic to infringe, in circumstances where the generic has not yet obtained a marketing authorisation.

Inside Life Sciences Issues

How can we help you?
Help

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

Crisis Hotline

I'm a client

I'm looking for advice

Something else